nyse

Bayer’s Monsanto acquisition to face politically charged scrutiny

WASHINGTON D.C./NEW YORK (Reuters) – As the global agricultural sector races to consolidate, Bayer AG's $66 billion all-cash deal to acquire Monsanto Co will test growing political and consumer unease in the United States and abroad over…

Go here to see the original: 
Bayer’s Monsanto acquisition to face politically charged scrutiny

nyse

Bayer’s Monsanto acquisition to face politically charged scrutiny

WASHINGTON D.C./NEW YORK (Reuters) – As the global agricultural sector races to consolidate, Bayer AG's $66 billion all-cash deal to acquire Monsanto Co will test growing political and consumer unease in the United States and abroad over the future of food production. Bayer’s pesticide-focused agricultural business has few overlaps with Monsanto's dominant seed franchise, according to the companies' executives. Monsanto and Bayer “have chosen to do a deal …

See original here: 
Bayer’s Monsanto acquisition to face politically charged scrutiny

nyse

Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change

U.S. drugmaker Pfizer Inc and Ireland-based Allergan Plc walked away from their $160 billion merger on Wednesday, a major win for President Barack Obama, who has been pushing to curb deals in which companies move overseas to cut taxes. Pfizer said the decision was driven by new U.S. Treasury rules aimed at such deals, called inversions. The merger would have allowed New York-based Pfizer

See original here:
Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change

nyse

Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change

U.S. drugmaker Pfizer Inc and Ireland-based Allergan Plc walked away from their $160 billion merger on Wednesday, a major win for President Barack Obama, who has been pushing to curb deals in which companies move overseas to cut taxes. Pfizer said the decision was driven by new U.S. Treasury rules aimed at such deals, called inversions. The merger would have allowed New York-based Pfizer to cut its tax bill by an estimated $1 billion annually by domiciling in Ireland, where tax rates are lower.

More here: 
Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change

« Previous Page